PSIX Q1 2026 Earnings EPS Falls Short of Estimates by Over 52 C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage MU Q1 2026 Earnings Strong EPS Beat Drives 19 Stock Surge TBPH Q1 2026 Earnings Narrower Loss Buoys Investor Sentiment Despite Zero Revenue COMPASS Pathways Plc Q1 2026 Earnings Narrower Loss Provides Hope Amid PreRevenue Stage DMIIR Rights Hover at 009 as Flat Trading Persists for Drugs Made In America Acquisition II Corp Intrepid Potash Inc IPI Pulls Back From Resistance Settles Near 3935 Rubico Inc RUBI Pulls Back Slightly as Stock Trades Near Key Support Northann Corp NCL Surges 10 Momentum Building or ShortTerm Rally Galata Acquisition Corp II Warrants Hold Steady at 030 as Key Levels Remain Defined Shoulder Innovations Inc SI Consolidates Near Key Support Level After Flat Trading Day Northpointe Bancshares NPB Slips 159 as Stock Approaches Key Support Silo Pharma Inc SILO Rallies 399 as Biotech Sentiment Improves Key Levels in Focus Mainz Biomed QUCY Slides 65 as Stock Tests Key Support Zone Spectrum Brands SPB Surges 373 as Volume Spikes Key Levels to Watch ORGN Q4 2025 Earnings Massive EPS Miss Highlights Ongoing Operational Hurdles